The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response
Open accessAbstract
Recent studies have shown that a carbohydrate-binding protein, galectin-3, is a novel pro-angiogenic molecule. The mechanism by which galectin-3 promotes angiogenesis remains unknown. We demonstrate here that galectin-3 is a mediator of vascular endothelial growth factor (VEGF)- and basic fibroblast growth factor (bFGF)-mediated angiogenic response. Angiogenesis assays revealed that galectin-3 inhibitors, β-lactose and dominant-negative galectin-3, reduce VEGF- and bFGF-mediated angiogenesis in vitro and that VEGF- and bFGF-mediated angiogenic response is reduced in galectin-3 knockdown cells and Gal3−/− animals. Integrin αvβ3 was identified as the major galectin-3–binding protein and anti-αv, -β3, and -αvβ3 integrin function-blocking antibodies significantly inhibited the galectin-3–induced angiogenesis. Furthermore, galectin-3 promoted the clustering of integrin αvβ3 and activated focal adhesion kinase. Knockdown of GnTV, an enzyme that synthesizes high-affinity glycan ligands for galectin-3, substantially reduced: (a) complex N-glycans on αvβ3 integrins and (b) VEGF- and bFGF-mediated angiogenesis. Collectively, these data suggest that galectin-3 modulates VEGF- and bFGF-mediated angiogenesis by binding via its carbohydrate recognition domain, to the GnTV synthesized N-glycans of integrin αvβ3, and subsequently activating the signaling pathways that promote the growth of new blood vessels. These findings have broad implications for developing novel, carbohydrate-based therapeutic agents for inhibition of angiogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070 · cited 1×
“, 2003), and nonocular diseases, such as cancer (Carmeliet and Jain, 2000) and rheumatoid arthritis (Koch, 1998).”
BackgroundHynes (2002) · doi:10.1016/s0092-8674(02)00971-6 · Cited by 8,606
Giancotti, F. G., & Ruoslahti, E. (1999) · Science · doi:10.1126/science.285.5430.1028 · Cited by 3,869
Requirement of Vascular Integrin α v β 3 for Angiogenesis
Brooks, P. C., Clark, R. A. F., & Cheresh, D. A. (1994) · Science · doi:10.1126/science.7512751 · Cited by 3,020
Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice
llić, D., Furuta, Y., Kanazawa, S., Takeda, N., Sobue, K., Nakatsuji, N., Nomura, S., Fujimoto, J., Okada, M., Yamamoto, T., et al. (1995) · Nature · doi:10.1038/377539a0 · Cited by 1,830
Basement membranes: structure, assembly and role in tumour angiogenesis
Kalluri, R. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1094 · Cited by 1,748
Integrin signalling during tumour progression
Guo, W., & Giancotti, F. G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1490 · Cited by 1,471
Tonnesen, M. G., Feng, X., & Clark, R. A. F. (2000) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1087-0024.2000.00014.x · Cited by 1,463
Focal adhesion kinase: the first ten years
Parsons, J. T. (2003) · Journal of Cell Science · doi:10.1242/jcs.00373 · Cited by 1,373
Definition of Two Angiogenic Pathways by Distinct α v Integrins
Friedlander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A., & Cheresh, D. A. (1995) · Science · doi:10.1126/science.270.5241.1500 · Cited by 1,321
Cross, M. J., & Claesson-Welsh, L. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01676-x · Cited by 989
Oligosaccharide specificity of galectins: a search by frontal affinity chromatography
Hirabayashi, J., Hashidate, T., Arata, Y., Nishi, N., Nakamura, T., Hirashima, M., Urashima, T., Oka, T., Futai, M., Muller, W. E. G., et al. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00311-2 · Cited by 926
Regulation of Cytokine Receptors by Golgi N-Glycan Processing and Endocytosis
Partridge, E. A., Le Roy, C., Di Guglielmo, G. M., Pawling, J., Cheung, P., Granovsky, M., Nabi, I. R., Wrana, J. L., & Dennis, J. W. (2004) · Science · doi:10.1126/science.1102109 · Cited by 735
Role of αvβ3 integrin in the activation of vascular endothelial growth factor receptor-2
Soldi, R., Mitola, S., Strasly, M., Defilippi, P., Tarone, G., & Bussolino, F. (1999) · The EMBO Journal · doi:10.1093/emboj/18.4.882 · Cited by 626
Pola, R., Ling, L. E., Silver, M., Corbley, M. J., Kearney, M., Blake Pepinsky, R., Shapiro, R., Taylor, F. R., Baker, D. P., Asahara, T., et al. (2001) · Nature Medicine · doi:10.1038/89083 · Cited by 612
Suppression of tumor growth and metastasis in Mgat5-deficient mice
Granovsky, M., Fata, J., Pawling, J., Muller, W. J., Khokha, R., & Dennis, J. W. (2000) · Nature Medicine · doi:10.1038/73163 · Cited by 569 · cited 1×
“GnTV animals, generated by Dennis and collaborators (Granovsky et al., 2000), were obtained from the Consortium for Functional Glycomics (The Scripps Research Institute).”
MethodCummings, R. D., & Kornfeld, S. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33746-3 · Cited by 541
Gardner, T. W., Antonetti, D. A., Barber, A. J., LaNoue, K. F., & Levison, S. W. (2002) · Survey of Ophthalmology · doi:10.1016/s0039-6257(02)00387-9 · Cited by 535
Ahmad, N., Gabius, H.-J., André, S., Kaltner, H., Sabesan, S., Roy, R., Liu, B., Macaluso, F., & Brewer, C. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312834200 · Cited by 517
Galectin-3 and Galectin-1 Bind Distinct Cell Surface Glycoprotein Receptors to Induce T Cell Death
Stillman, B. N., Hsu, D. K., Pang, M., Brewer, C. F., Johnson, P., Liu, F.-T., & Baum, L. G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.778 · Cited by 507
Self-citationAngiogenesis: Implications for rheumatoid arthritis
Koch, A. E. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199806)41:6<951::aid-art2>3.0.co;2-d · Cited by 504
Galectin-3 Induces Endothelial Cell Morphogenesis and Angiogenesis
Nangia-Makker, P., Honjo, Y., Sarvis, R., Akahani, S., Hogan, V., Pienta, K. J., & Raz, A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64959-0 · Cited by 446
Targeted Disruption of the Galectin-3 Gene Results in Attenuated Peritoneal Inflammatory Responses
Hsu, D. K., Yang, R.-Y., Pan, Z., Yu, L., Salomon, D. R., Fung-Leung, W.-P., & Liu, F.-T. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64975-9 · Cited by 428
Self-citationNangia-Makker, P., Hogan, V., Honjo, Y., Baccarini, S., Tait, L., Bresalier, R., & Raz, A. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.24.1854 · Cited by 424
A model of angiogenesis in the mouse cornea.
Kenyon, B. M., Voest, E. E., Chen, C. C., Flynn, E. A., Folkman, J., & D’Amato, R. J. (1996) · PubMed · Cited by 407
Integrin and Growth Factor Receptor Crosstalk
Eliceiri, B. P. (2001) · Circulation Research · doi:10.1161/hh2401.101084 · Cited by 395
Leavesley, D. I., Schwartz, M. A., Rosenfeld, M., & Cheresh, D. A. (1993) · The Journal of cell biology · doi:10.1083/jcb.121.1.163 · Cited by 391
Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist
Storgard, C. M., Stupack, D. G., Jonczyk, A., Goodman, S. L., Fox, R. I., & Cheresh, D. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3756 · Cited by 310
Drake, C. J., Cheresh, D. A., & Little, C. D. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.7.2655 · Cited by 307
Shen, T.-L., Park, A. Y.-J., Alcaraz, A., Peng, X., Jang, I., Koni, P., Flavell, R. A., Gu, H., & Guan, J.-L. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200411155 · Cited by 304
Characterization of the receptors for vascular endothelial growth factor.
Vaisman, N., Gospodarowicz, D., & Neufeld, G. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45395-6 · Cited by 303
Stupack, D. G., & Cheresh, D. A. (2004) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(04)64009-9 · Cited by 295
Borges, E., Jan, Y., & Ruoslahti, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007040200 · Cited by 293
Adhesion events in angiogenesis
Eliceiri, B. P., & Cheresh, D. A. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00252-0 · Cited by 287 · cited 2×
“Specifically, it has been reported that VEGFR2 binds to v3 integrin (Soldi et al., 1999; Borges et al., 2000; Eliceiri, 2001; Eliceiri and Cheresh, 2001), and this binding occurs via the extracellular domain of the integrin and enhances the activity of the growth factor receptor (Borges et al.”
BackgroundHsu, D. K., Zuberi, R. I., & Liu, F. T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49693-2 · Cited by 264
Self-citationBraren, R., Hu, H., Kim, Y. H., Beggs, H. E., Reichardt, L. F., & Wang, R. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200506184 · Cited by 246
Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties
Matarrese, P., Fusco, O., Tinari, N., Natoli, C., Liu, F.-T., Semeraro, M. L., Malorni, W., & Iacobelli, S. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000215)85:4<545::aid-ijc17>3.0.co;2-n · Cited by 244
Self-citationCell–matrix adhesion complexes: Master control machinery of cell migration
Lock, J. G., Wehrle-Haller, B., & Strömblad, S. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2007.10.001 · Cited by 227
Galectin Binding to Mgat5-Modified N-Glycans Regulates Fibronectin Matrix Remodeling in Tumor Cells
Lagana, A., Goetz, J. G., Cheung, P., Raz, A., Dennis, J. W., & Nabi, I. R. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.3181-3193.2006 · Cited by 207
Integrin signaling is critical for pathological angiogenesis
Mahabeleshwar, G. H., Feng, W., Phillips, D. R., & Byzova, T. V. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060807 · Cited by 206
Concerted regulation of focal adhesion dynamics by galectin-3 and tyrosine-phosphorylated caveolin-1
Goetz, J. G., Joshi, B., Lajoie, P., Strugnell, S. S., Scudamore, T., Kojic, L. D., & Nabi, I. R. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200709019 · Cited by 197
Role of integrins in angiogenesis
Brooks, P. C. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00381-4 · Cited by 193
Integrins in angiogenesis: multitalented molecules in a balancing act
Hodivala‐Dilke, K., Reynolds, A. R., & Reynolds, L. E. (2003) · Cell and Tissue Research · doi:10.1007/s00441-003-0774-5 · Cited by 183
Angiogenesis in Embryonic Development—A Review
Breier, G. (2000) · Placenta · doi:10.1053/plac.1999.0525 · Cited by 183
Variant glycosylation: an underappreciated regulatory mechanism for $beta;1 integrins
Bellis, S. L. (2004) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2004.03.012 · Cited by 154
Macrophage surface glycoproteins binding to galectin-3 (Mac-2-antigen)
Dong, S., & Hughes, R. C. (1997) · Glycoconjugate Journal · doi:10.1023/a:1018554124545 · Cited by 150
Ohannesian, D. W., Lotan, D., Thomas, P., Jessup, J. M., Fukuda, M., Gabius, H., & Lotan, R. (1995) · PubMed · Cited by 144
FAK promotes organization of fibronectin matrix and fibrillar adhesions
Ilić, D., Kovačič-Milivojević, B., Johkura, K., Schlaepfer, D. D., Tomašević, N., Han, Q., Kim, J., Howerton, K., Baumbusch, C., Ogiwara, N., et al. (2003) · Journal of Cell Science · doi:10.1242/jcs.00845 · Cited by 135
John, C. M., Leffler, H., Kahl‐Knutsson, B., Svensson, I., & Jarvis, G. A. (2003) · PubMed · Cited by 130
Saravanan, C., Liu, F., Gipson, I. K., & Panjwani, N. (2009) · Journal of Cell Science · doi:10.1242/jcs.045674 · Cited by 128
Self-citationAltin, J. G., & Pagler, E. (1995) · Analytical Biochemistry · doi:10.1006/abio.1995.1054 · Cited by 124
Angiogenesis and its control in the female reproductive system
Fraser, H. M., & Lunn, S. F. (2000) · British Medical Bulletin · doi:10.1258/0007142001903364 · Cited by 122
Wet age-related macular degeneration
KULKARNI, A., & Kuppermann, B. D. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.003 · Cited by 99
Guo, H., Lee, I., Bryan, B. T., & Pierce, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m413532200 · Cited by 51
Gu, Y., Bauer, T. R., Ackermann, M. R., Smith, C. W., Kehrli, M. E., Starost, M. F., & Hickstein, D. D. (2004) · PubMed · Cited by 26
Cited by
Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
Schaaf, M. B., Garg, A. D., & Agostinis, P. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0061-0 · Cited by 629
Deterministic reprogramming of neutrophils within tumors
Ng, M. S. F., Kwok, I., Tan, L., Shi, C., Cerezo-Wallis, D., Tan, Y., Leong, K., Calvo, G. F., Yang, K., Zhang, Y., et al. (2024) · Science · doi:10.1126/science.adf6493 · Cited by 389
Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z
Sciacchitano, S., Lavra, L., Morgante, A., Ulivieri, A., Magi, F., De Francesco, G., Bellotti, C., Salehi, L., & Ricci, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020379 · Cited by 377
An integrin β3-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition
Seguin, L., Kato, S., Franovic, A., Camargo, M. F., Lesperance, J., Elliott, K. C., Yebra, M., Mielgo, A., Lowy, A. M., Husain, H., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb2953 · Cited by 374
Galectin-3 – A jack-of-all-trades in cancer
Newlaczyl, A. U., & Yu, L.-G. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.09.003 · Cited by 362
Metadata
- Authors
- Markowska, A. I., Liu, F.-T., & Panjwani, N.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2010-08-16
- Volume
- 207
- Issue
- 9
- Pages
- 1981-1993
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2159166873
- Cited by
- 330
- References
- 55
- FWCI
- 7.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.